Melissa Moffitt, MD Melissa Moffitt, MD

Melissa Moffitt

Gynecologic Oncology

Specializing In:

Complex gynecologic surgeries Minimally invasive surgery including vaginal surgery laparoscopic surgery and robot-assisted laparoscopy Fertility sparing medical and surgical treatments for gynecologic malignancies Sexuality for women cancer survivors and pre-vivors

About Melissa Moffitt


Roswell Park Comprehensive Cancer Center

  • Assistant Professor of Oncology
  • Program Director, Gynecology Oncology Fellowship Program
  • Department of Gynecology Oncology


Education and Training:

  • 2000-2004 - MD - University of California, Davis, CA


  • 2005-2008 - UMass Memorial, Worcester, MA
  • 2004-2005 - University of California, Los Angeles, CA


  • 2008-2011 - University of Southern California

Board Certification:

  • Gynecologic Oncology Diplomat, American Board of Obstetrics and Gynecology
  • Obstetrics and Gynecology Diplomat, American Board of Obstetrics and Gynecology

Professional Memberships:

  • Society of Gynecologic Oncology
  • Association of Professors of Gynecology and Obstetrics
  • The Scientific Network on Female Sexual Health and Cancer

Professional Experience:

  • 2011-2020 - Assistant Professor, Gynecologic Oncology, Associate Residency Program Director, Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR

Featured on Cancer Talk


Full Publications list on PubMed
  1. Grant DJ, Pejovic T, Moffitt M, et al. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women. Cancer Med. 2019 May;8(5):2503-2513. doi: 10.1002/cam4.1996
  2. Batman S, Morgan T, Brunetti M, Strandabø RAU, Micci F, Moffitt M, Pejovic T. Primary mediastinal choriocarcinoma in a female patient: Case report and review of the literature. Gynecol Oncol Rep. 2018 Nov;26:99-101. doi: 10.1016/j.gore.2018.10.013. eCollection 2018 Nov.
  3. Glubb DM, Pejovic T, Moffitt M, et al. Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci. Oncotarget. 2017 Sep 12;8(39):64670-64684. doi: 10.18632/oncotarget.18501. eCollection 2017 Sep 12.
  4. Phelan CM, Pejovic T, Moffitt M, et al. Nat Genet. 2017 May;49(5):680-691. doi: 10.1038/ng.3826. Epub 2017 Mar 27. PubMed PMID:28346442; PubMed Central PMCID:PMC5612337.
  5. Campan M, Moffitt M, Houshdaran S, Shen H, Widschwendter M, Daxenbichler G, Long T, Marth C, Laird-Offringa IA, Press MF, Dubeau L, Siegmund KD, Wu AH, Groshen S, Chandavarkar U, Roman LD, Berchuck A, Pearce CL, Laird PW. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. PLoS One. 2011;6(12):e28141. doi: 10.1371/journal.pone.0028141. Epub 2011 Dec 7.